Sol-Gel Technologies, which is developing topical acne creams that deliver treatment via microcapsules, raised $75 million by offering 6.25 million shares at $12, the midpoint of the $11 to $13 range. It had previously planned to offer 5 million shares at the same range. Sol-Gel Technologies plans to list on the Nasdaq under the symbol SLGL. Jefferies and BMO Capital Markets acted as lead managers on the deal.
